Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica

被引:219
作者
Eaves, DJ
Randall, L
Gray, DT
Buckley, A
Woodward, MJ
White, AP
Piddock, LJV [1 ]
机构
[1] Univ Birmingham, Div Immun & Infect, Antimicrobial Agents Res Grp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Stat Advisory Serv, Birmingham B15 2TT, W Midlands, England
[3] Vet Labs Agcy, Dept Food & Environm Safety, Surrey, England
关键词
D O I
10.1128/AAC.48.10.4012-4015.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Salmonella enterica isolates (n = 182) were examined for mutations in the quinolone resistance-determining region of gyrA, gyrB, parC, and parE. The frequency, location, and type of GyrA substitution varied with the serovar. Mutations were found in parC that encoded Thr57-Ser, Thr66-Ile, and Ser80-Arg substitutions. Mutations in the gyrB quinolone resistance-determining region were located at codon Tyr420-Cys or Arg437-Len. Novel mutations were also found in parE encoding Glu453-Gly, His461-Tyr, Ala498-Thr, Val512-Gly, and Ser518-Cys. Although it is counterintuitive, isolates with a mutation in both gyrA and parC were more susceptible to ciprofloxacin than were isolates with a mutation in gyrA alone.
引用
收藏
页码:4012 / 4015
页数:4
相关论文
共 16 条
[1]   Is it time to change fluoroquinolone breakpoints for Salmonella spp.? [J].
Aarestrup, FM ;
Wiuff, C ;
Molbak, K ;
Threlfall, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :827-829
[2]  
ANDERRSSON DL, 1998, LAKARTIDNINGEN, V95, P3943
[3]  
Andersson D I, 1998, Lakartidningen, V95, P3943
[4]   Determination of minimum inhibitory concentrations [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :5-16
[5]   Virulence of antibiotic-resistant Salmonella typhimurium [J].
Björkman, J ;
Hughes, D ;
Andersson, DI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3949-3953
[6]   Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography [J].
Eaves, DJ ;
Liebana, E ;
Woodward, MJ ;
Piddock, LJV .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4121-4125
[7]   Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany [J].
Guerra, B ;
Malorny, B ;
Schroeter, A ;
Helmuth, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2059-2059
[8]   Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro [J].
Hansen, H ;
Heisig, P .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2003, 9 (01) :25-32
[9]   European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria [J].
Kahlmeter, G ;
Brown, DFJ ;
Goldstein, FW ;
MacGowan, AP ;
Mouton, JW ;
Österlund, A ;
Rodloff, A ;
Steinbakk, M ;
Urbaskova, P ;
Vatopoulos, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) :145-148
[10]   Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong [J].
Ling, JM ;
Chan, EW ;
Lam, AW ;
Cheng, AF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3567-3573